Matt Vogelhuber

Matt Vogelhuber serves as the Chief Executive Officer at fluidIQ, a medical devices company focused on improving quality of life through fluidic solutions, since December 2020. Concurrently, Vogelhuber has been involved in business development with Kringle Pharma and as Principal and Managing Partner at PerimeterPHARMA Solutions, LLC, specializing in commercialization strategies and alliance management in the pharma and biotech sectors. Previous leadership roles include Director at Aegle Therapeutics, East Coast/South Central Oncology Sales Director at Myriad Genetics, President and CEO at Concordant Pharmaceuticals, and various positions at Eli Lilly and Company, including Sales Director overseeing significant annual sales and operational budgets. Vogelhuber holds degrees from the University of Pittsburgh, The Ohio State University, Louisiana State University, and the University of Miami.